Opioid Update, May 30, 2017 by unknown
Iowa Department of Public Health 
Division of Behavioral Health  
Opioid Update for Wednesday, May 30, 2018 
 
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Opioid News 
• Department Efforts 
• Upcoming Training 
 
Opioid News 
 
FDA approves non-opioid for opioid withdrawal symptoms 
The Food and Drug Administration (FDA) last week approved the first non-opioid medication for 
the treatment of opioid withdrawal symptoms. Lucemyra (generic name: lofexidine) was shown 
to result in less severe withdrawal symptoms and to facilitate completion of a withdrawal 
protocol in two placebo-controlled studies. 
 
Lucemyra, which suppresses the neurochemical surge that produces troubling symptoms of 
opioid withdrawal that include muscle spasms, stomach cramps and heart pounding, is 
expected to be available in the U.S. market in August. Officials at drug maker US WorldMeds 
referred to the FDA's action as a “milestone approval,” given that the challenge of opioid 
withdrawal often can get overlooked in discussions of how to address the opioid crisis. The fear 
and pain associated with withdrawal symptoms often sends individuals back to opioid use. The 
FDA reviewed the drug application for Lucemyra under its priority review procedures. 
 
Lucemyra is seen as having significant potential for patients seeking to be initiated on injectable 
naltrexone treatment for opioid dependence, as this requires a patient to be completely opioid-
free prior to initiation.  The medication is designed to be used during the period of peak 
withdrawal symptoms, usually occurring five to seven days after last use of opioids.  
 
For more information on Lucemyra, please click on the following link: Lucemyra 
 
Stem Cells for Pain? Golfer Jack Nicklaus Thinks So 
 
In a recent CNN article, golf legend Jack Nicklaus talked about his aggravating back pain that 
he dealt with for most of his professional career. Having tried things like cortisone injections and 
surgery, but still having pain, the golfer tried an approach gaining popularity using his own stem 
cells.   
 
The procedure Nicklaus underwent is part of a burgeoning approach referred to as 
Regenerative Medicine.  For Nicklaus, the process involved harvesting cells from his abdominal 
area, and after processing, injecting the cells back into his body.  Nicklaus reported while he 
didn’t feel immediate relief, he did notice the pain he used to feel while actively playing golf had 
subsided after a few months.   
 
The approach, while it still has to gain FDA approval, could mean significant changes in how 
pain and other medical issues are treated.  
 
To read the entire article, please click on the following link: CNN  
Department Efforts 
 
Health Initiatives for People Who Inject Drugs 
The Iowa Department of Health’s Bureau of HIV, STD and Hepatitis will be starting a new 
project to address cross-sector determinants of health impacting people who use or inject drugs. 
This program is supported by a new initiative from AmeriCorps VISTA to support individuals in 
accessing treatment or prevention services related to opioid addiction recovery. The Health 
Initiatives for People Who Inject Drugs project will be recruiting three AmeriCorps VISTA 
members to support programming and responsive strategic planning for individuals at 
heightened risk for infectious disease transmission or substance use disorders due to injection 
drug use. The three AmeriCorps VISTA members will support ongoing care interventions to 
ensure that providers and key stakeholders (e.g., law enforcement, corrections, mental health, 
substance use disorder treatment, and housing) around the state are equipped with tools and 
interventions incorporating health equity, trauma-informed care, and harm reduction.  
The three AmeriCorps VISTA members – Client Engagement Specialist, Care and Prevention 
Support Specialist, and Systems Engagement Specialist – will collaborate closely with the 
Bureau’s HIV and Substance Use Coordinator to research, develop, and implement a statewide 
steering committee addressing the intersectional needs of those directly impacted by drug use. 
Starting in July 2018, the team will be reaching out to stakeholders around the state to discuss 
planning around a variety of topics including, but not limited to: rural substance use, provider 
and patient education, safe disposal, heroin and opioids, methamphetamine, law enforcement 
and emergency services engagement, low-barrier housing, and more.  
If you are interested in learning more about the three AmeriCorps VISTA positions, the Health 
Initiatives for People Who Inject Drugs project, or participation in the statewide steering 
committee, please contact Joe Caldwell, HIV and Substance Use Coordinator at 
joe.caldwell@idph.iowa.gov. 
 
Upcoming Trainings 
 
IHC Care Coordination Conference 
 
On June 12th, the Iowa Healthcare Collaborative will be hosting the IHC Care Coordination 
Conference.  From chronic care management to behavioral health integration and combatting 
opioids, this conference brings together national content experts with local champions and best 
practice exemplars that can attest to making change happen and experiencing boots-on-the-
ground improvements. Don’t miss your chance to connect with fellow champions and discover 
opportunities for collaboration! 
 
To learn more or register for the conference, please click on the following link: IHC 
 
The Intersection of Opioid Abuse, Overdose, and Suicide: Understanding the 
Connections 
 
SAMHSA's Center for the Application of Prevention Technologies (CAPT) and SPRC are co-
hosting a webinar that will explore the connections between opioid abuse, overdose, and 
suicide. Presenters will examine current research on the relationship between these problems, 
discuss opportunities for cross-sector collaboration to address them, and feature examples from 
the field where this work is already underway. This webinar will take place on June 5th from 3 to 
4:30 p.m. ET and is the first in a two-part series. The second webinar will explore the 
relationship of chronic pain to opioid abuse, overdose, and suicide, and will take place on June 
28th--more details to come! 
 
To learn more or register for the webinar, please click on the following link: CAPT 
